Four Weeks of Treatment With Liraglutide Reduces Insulin Dose Without Loss of Glycemic Control in Type 1 Diabetic Patients With and Without Residual β-Cell Function
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.